Antonello E Rigamonti
Overview
Explore the profile of Antonello E Rigamonti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rigamonti A, Rubino F, Caroli D, Bondesan A, Mai S, Cella S, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274429
Obesity is characterized by increased oxidative stress, which, in a vicious circle, promotes chronic low-grade inflammation. Melatonin, a well-documented antioxidant, might be useful as a supplement to enhance the cardiometabolic...
2.
Rigamonti A, Polledri E, Favero C, Caroli D, Bondesan A, Grugni G, et al.
Front Endocrinol (Lausanne)
. 2024 May;
15:1386265.
PMID: 38812813
Introduction: Prader-Willi syndrome (PWS) is a rare disease, which shows a peculiar clinical phenotype, including obesity, which is different from essential obesity (EOB). Metabolomics might represent a valuable tool to...
3.
Rigamonti A, Cas M, Caroli D, Bondesan A, Cella S, Paroni R, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569827
Ceramide risk score (CERT1, ceramide test 1), based on specific ceramides (Cers) and their corresponding ratios in the plasma, has been reported as a promising biochemical marker for primary and...
4.
Rigamonti A, Cas M, Caroli D, De Col A, Cella S, Paroni R, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108620
Metabolic syndrome is nosographically defined by using clinical diagnostic criteria such as those of the International Diabetes Federation (IDF) ones, including visceral adiposity, blood hypertension, insulin resistance and dyslipidemia. Due...
5.
Rigamonti A, Frigerio G, Caroli D, De Col A, Cella S, Sartorio A, et al.
Nutrients
. 2023 Feb;
15(3).
PMID: 36771236
Metabolomics applied to assess the response to a body weight reduction program (BWRP) may generate valuable information concerning the biochemical mechanisms/pathways underlying the BWRP-induced cardiometabolic benefits. The aim of the...
6.
Rigamonti A, Bollati V, Favero C, Albetti B, Caroli D, De Col A, et al.
Int J Environ Res Public Health
. 2022 Dec;
19(23).
PMID: 36497566
Circadian rhythms are generated by a series of genes, collectively named genes, which act as a self-sustained internal 24 h timing system in the body. Many physiological processes, including metabolism...
7.
Rigamonti A, Bollati V, Favero C, Albetti B, Caroli D, Abbruzzese L, et al.
J Clin Med
. 2022 Aug;
11(16).
PMID: 36012914
Obesity and aging share common molecular and cellular mechanisms underlying the pathophysiology of cardiovascular diseases (CVD), which occur frequently in both conditions. DNA methylation (DNAm) age, a biomarker of the...
8.
Dolci C, Rigamonti A, Cappella A, Gibelli D, Grugni G, Caroli D, et al.
Biology (Basel)
. 2022 Aug;
11(8).
PMID: 36009775
Background: Prader-Willi syndrome (PWS) is a rare genomic imprinting disorder associated to a complex neurodevelopmental phenotype and a distinctive facial appearance. The study investigated the relationships between the quantitative facial...
9.
Rigamonti A, Bondesan A, Rondinelli E, Cella S, Sartorio A
Metabolites
. 2022 Jun;
12(6).
PMID: 35736501
In the original publication [...].
10.
Rigamonti A, Bondesan A, Rondinelli E, Cella S, Sartorio A
Metabolites
. 2022 Feb;
12(2).
PMID: 35208229
The aspartate transaminase to platelet ratio index (APRI) has been proposed as an easy-to-use biochemical marker in obese adults with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH)....